Opioid Analgesia for Medical Abortion
Authors:
- Lisa L. BayerLBLisa L. Bayer
- Paula BednarekPBPaula Bednarek
- Bharti GargBGBharti Garg
- Jeffery T. JensenJJJeffery T. Jensen
- Alison B. EdelmanAEAlison B. Edelman
- 4 November 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 134 (6) , 1163-1170
Abstract
OBJECTIVE: To estimate the effect of oral opioids on patient pain during first-trimester medical abortion. METHODS: We conducted a randomized, double-blind, placebo-controlled trial where patients up to 10 0/7 weeks of gestation undergoing a medical abortion with mifepristone and misoprostol took 10 mg oral oxycodone or placebo at onset of painful cramping. Additionally, all patients received 800-mg ibuprofen tablets, 4-mg ondansetron oral dissolving tablets, and a written prescription for adjunctive pain medication (six tablets oxycodone 5 mg). Participants used a text-messaging service to report pain scores on a numerical rating scale from 0 to 10 (0 being no pain, 10 being worst pain) for 24 hours at start of misoprostol dosing. The primary outcome was maximum pain experienced within 24 hours postmisoprostol. Our secondary outcomes were maximum pain stratified by gestational age (less than 7 weeks of gestation, 7–10 weeks of gestation), duration of maximum pain, use of adjunctive medication, presence of nausea or vomiting, and satisfaction. We needed at least 76 participants per group to differentiate a clinically important pain difference of 2 points on the numerical rating scale. RESULTS: From May 2017 to May 2018, we randomized 172 participants (placebo group with 86, oxycodone group with 86). The study groups had comparable baseline characteristics. We found no difference between groups in median maximum pain scores (placebo 8 [range 1–10], oxycodone 8 [range 2–10], P=.92) and the median duration of maximum pain (placebo 0.75 hours range 0.01–15 vs oxycodone 1 hour range 0.02–10, P=.39). Groups were also similar in the proportion obtaining (placebo 62%, oxycodone 49%, P=.09) and using (placebo 48%, oxycodone 40%, P=.28) adjunctive medication, experiencing nausea or vomiting (placebo 59%, oxycodone 65%, P=.43) and reported satisfaction with pain medications (placebo 62%, oxycodone 65%, P=.63). CONCLUSION: Oxycodone does not reduce the maximum level of pain experienced by women undergoing medical abortion up to 10 0/7 weeks of gestation or improve satisfaction. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03139240.Keywords
This publication has 14 references indexed in Scilit:
- Practice Bulletin No. 143Obstetrics & Gynecology, 2014
- Abortion Incidence and Service Availability In the United States, 2011Perspectives on Sexual and Reproductive Health, 2014
- Prophylactic Compared With Therapeutic Ibuprofen Analgesia in First-Trimester Medical AbortionObstetrics & Gynecology, 2013
- Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostolContraception, 2009
- Two Distinct Oral Routes of Misoprostol in Mifepristone Medical AbortionObstetrics & Gynecology, 2008
- Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: A randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain modelClinical Therapeutics, 2005
- The Pharmacokinetics of OxycodoneJournal of Pain & Palliative Care Pharmacotherapy, 2005
- Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative painThe Journal of Pain, 2003
- Clinically Important Changes in Acute Pain Outcome MeasuresJournal of Pain and Symptom Management, 2003
- Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trialBJOG: An International Journal of Obstetrics & Gynaecology, 2000